Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.
D058186:Acute Kidney Injury / Q000188:drug therapy; D002112:Calcifediol; D002117:Calcitriol; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy* / Q000517:prevention & control; D004100:Dihydroxycholecalciferols / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D006887:Hydroxycholecalciferols / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D006934:Hypercalcemia / Q000139:chemically induced; D010018:Osteomalacia / Q000188:drug therapy; D006435:Renal Dialysis; D012306:Risk; D014511:Uremia / Q000150:complications / Q000188:drug therapy*
D004100:Dihydroxycholecalciferols; D006887:Hydroxycholecalciferols; D002117:Calcitriol; D002112:Calcifediol